STOCK TITAN

GeneDx: Deep Track Capital reports 6.01% ownership stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

GeneDx Holdings Corp. is the issuer named in a joint Schedule 13G in which Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin each report beneficial ownership of 1,800,000 shares of its Class A common stock as of November 17, 2026. The reports reflect the same position, not three separate holdings. David Kroin may be considered a control person of Deep Track Capital.

Each reporting person reports 6.01% of the class and shared voting and dispositive power over 1,800,000 shares, with no sole voting or dispositive power. The percentage is based on 29,972,493 shares outstanding as of November 2, 2026.

Beneficial ownership 1,800,000 shares Each of the three reporting persons reports this amount as of November 17, 2026.
Percent of class 6.01% Reported by each reporting person; based on shares outstanding as of November 2, 2026.
Shares outstanding 29,972,493 shares As of November 2, 2026.
beneficial ownership regulatory
"Amount beneficially owned: 1,800,000"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared Voting Power regulatory
"Shared Voting Power 1,800,000"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 1,800,000"
Joint Filing Statement regulatory
"JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many WGS shares do Deep Track and David Kroin report owning?

The reporting persons each report beneficial ownership of 1,800,000 shares of GeneDx’s Class A common stock. These are overlapping reports of the same position, not separate amounts to add together.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





81663L200

(CUSIP Number)
11/10/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Deep Track Capital, LP
Signature:/s/ David Kroin
Name/Title:David Kroin, Managing Member of the General Partner of the Investment Adviser
Date:11/17/2026
Deep Track Biotechnology Master Fund, Ltd.
Signature:/s/ David Kroin
Name/Title:David Kroin, Director
Date:11/17/2026
David Kroin
Signature:/s/ David Kroin
Name/Title:David Kroin
Date:11/17/2026
Exhibit Information

Item 4: Information with respect to the Reporting Persons' ownership of the Class A Common Stock as of November 17, 2026, is incorporated by reference to items (5) - (9) and (11) of the cover page of the respective Reporting Person. The amount beneficially owned by each Reporting Person is determined using 29,972,493 shares outstanding as of November 2, 2026, as reported by the issuer on its 10-Q filed with the SEC on November 9, 2026. JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Dated: November 17, 2026 Deep Track Capital, LP By: /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser Deep Track Biotechnology Master Fund, Ltd. By: /s/ David Kroin David Kroin, Director David Kroin By: /s/ David Kroin David Kroin

Keep reading